Skip to content
10-Q

Quarterly Report

Akoya Biosciences, Inc.

0001558370-25-007462

← back to feed
Filed
May 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Apr 30, 2025 49.88M sh
Shares Diluted Q1 2025 · Mar 31, 2025 49.66M sh
Shares Diluted Q1 2025 · Mar 31, 2024 49.19M sh
Capex Q1 2025 · Mar 31, 2025 $204K
Capex Q1 2025 · Mar 31, 2024 $810K
Operating Cash Flow Q1 2025 · Mar 31, 2025 −$7.21M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$20.82M
Short Term Debt Q1 2025 · Mar 31, 2025 $76.49M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $20.36M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $11.78M
Stockholders Equity Q1 2025 · Mar 31, 2025 −$5.89M
Stockholders Equity Q1 2025 · Dec 31, 2024 $7.6M
Stockholders Equity Q1 2025 · Mar 31, 2024 $32.72M
Stockholders Equity Q1 2025 · Dec 31, 2023 $53.77M
Current Liabilities Q1 2025 · Mar 31, 2025 $108.08M
Current Liabilities Q1 2025 · Dec 31, 2024 $29.44M
Total Liabilities Q1 2025 · Mar 31, 2025 $118.54M
Total Liabilities Q1 2025 · Dec 31, 2024 $117.41M
Current Assets Q1 2025 · Mar 31, 2025 $66.21M
Current Assets Q1 2025 · Dec 31, 2024 $76.73M
Total Assets Q1 2025 · Mar 31, 2025 $112.65M
Total Assets Q1 2025 · Dec 31, 2024 $125.01M
Eps Diluted Q1 2025 · Mar 31, 2025 −$0.32
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.48
Eps Basic Q1 2025 · Mar 31, 2025 −$0.32
Eps Basic Q1 2025 · Mar 31, 2024 −$0.48
Sga Expense Q1 2025 · Mar 31, 2025 $17.58M
Sga Expense Q1 2025 · Mar 31, 2024 $19.86M
Rd Expense Q1 2025 · Mar 31, 2025 $5.56M
Rd Expense Q1 2025 · Mar 31, 2024 $5.55M
Net Income Q1 2025 · Mar 31, 2025 −$15.65M
Net Income Q1 2025 · Mar 31, 2024 −$23.48M
Operating Income Q1 2025 · Mar 31, 2025 −$13.41M
Operating Income Q1 2025 · Mar 31, 2024 −$21.59M
Gross Profit Q1 2025 · Mar 31, 2025 $9.87M
Gross Profit Q1 2025 · Mar 31, 2024 $8.38M
Cost Of Revenue Q1 2025 · Mar 31, 2025 $6.77M
Cost Of Revenue Q1 2025 · Mar 31, 2024 $9.97M
Revenue Q1 2025 · Mar 31, 2025 $16.64M
Revenue Q1 2025 · Mar 31, 2024 $18.35M
Long Term Debt Q1 2025 · Dec 31, 2024 $76.18M